ETFis Series Trust I (BBP)
Management Company · ARCX · Series S000047354 · View on SEC EDGAR ↗
- Net assets
- $59.3M
- Holdings
- 63
- As of
- April 30, 2026 stale
- Top 10 holdings weight
- 26.74%
- Effective number of positions
- 51.3
- Positions above 1%
- 57
On this page
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Sector breakdown How the fund's holdings split across market sectors.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
Fund flows (SEC-reported)
- Last month (Apr 2026)
- +$4.3M
- Quarter ending Apr 2026
- +$12.4M
- Trailing 12 months
- +$24.1M
May 2025 – Apr 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 63 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| IMMUNITYBIO INC | 45256X103 | $2.8M | 4.80 | 401,005 | EC | US |
| DREYFUS GOVERNMENT CASH MANAGE | — | $1.9M | 3.15 | 1,868,134 | STIV | US |
| APELLIS PHARMACEUTICALS INC | 03753U106 | $1.5M | 2.59 | 37,509 | EC | US |
| KALVISTA PHARMACEUTICALS INC | 483497103 | $1.5M | 2.52 | 55,964 | EC | US |
| MODERNA INC | 60770K107 | $1.5M | 2.49 | 32,122 | EC | US |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | $1.4M | 2.44 | 430,167 | EC | US |
| MIRUM PHARMACEUTICALS INC | 604749101 | $1.4M | 2.39 | 14,558 | EC | US |
| AXSOME THERAPEUTICS INC | 05464T104 | $1.3M | 2.24 | 6,386 | EC | US |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | — | $1.2M | 2.06 | 22,754 | EC | GB |
| ROIVANT SCIENCES LTD | — | $1.2M | 2.06 | 42,821 | EC | BM |
| ZAI LAB LTD | 98887Q104 | $1.2M | 1.94 | 53,256 | EC | KY |
| LIGAND PHARMACEUTICALS | 53220K504 | $1.1M | 1.93 | 4,992 | EC | US |
| BIOCRYST PHARMACEUTICALS INC | 09058V103 | $1.1M | 1.93 | 125,015 | EC | US |
| TRAVERE THERAPEUTICS INC | 89422G107 | $1.1M | 1.93 | 27,170 | EC | US |
| NOVAVAX INC | 670002401 | $1.1M | 1.93 | 144,044 | EC | US |
| UNITED THERAPEUTICS CORP | 91307C102 | $1.1M | 1.84 | 1,914 | EC | US |
| GERON CORP | 374163103 | $1.1M | 1.81 | 695,861 | EC | US |
| BIONTECH SE | 09075V102 | $1.0M | 1.74 | 9,981 | EC | DE |
| AMGEN INC | 031162100 | $1.0M | 1.74 | 2,977 | EC | US |
| EXELIXIS INC | 30161Q104 | $1.0M | 1.74 | 23,148 | EC | US |
| BIOGEN INC | 09062X103 | $1.0M | 1.73 | 5,434 | EC | US |
| GILEAD SCIENCES INC | 375558103 | $1.0M | 1.73 | 7,859 | EC | US |
| TG THERAPEUTICS INC | 88322Q108 | $1.0M | 1.72 | 30,187 | EC | US |
| KRYSTAL BIOTECH INC | 501147102 | $1.0M | 1.71 | 3,866 | EC | US |
| LEGEND BIOTECH CORP | 52490G102 | $997K | 1.68 | 42,398 | EC | KY |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | $996K | 1.68 | 46,457 | EC | US |
| ARROWHEAD PHARMACEUTICALS INC | 04280A100 | $992K | 1.67 | 13,501 | EC | US |
| ASCENDIS PHARMA A/S | 04351P101 | $985K | 1.66 | 4,293 | EC | DK |
| AGIOS PHARMACEUTICALS INC | 00847X104 | $972K | 1.64 | 34,703 | EC | US |
| HALOZYME THERAPEUTICS INC | 40637H109 | $968K | 1.63 | 15,211 | EC | US |
| ARDELYX INC | 039697107 | $965K | 1.63 | 152,393 | EC | US |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | $957K | 1.61 | 17,750 | EC | US |
| INCYTE CORP | 45337C102 | $945K | 1.59 | 9,918 | EC | US |
| AURINIA PHARMACEUTICALS INC | 05156V102 | $919K | 1.55 | 59,707 | EC | CA |
| SAREPTA THERAPEUTICS INC | 803607100 | $918K | 1.55 | 43,955 | EC | US |
| REGENERON PHARMACEUTICALS | 75886F107 | $902K | 1.52 | 1,276 | EC | US |
| BRIDGEBIO PHARMA INC | 10806X102 | $895K | 1.51 | 12,592 | EC | US |
| VERTEX PHARMACEUTICALS INC | 92532F100 | $895K | 1.51 | 2,093 | EC | US |
| BEONE MEDICINES LTD | 07725L102 | $875K | 1.48 | 2,965 | EC | CH |
| IONIS PHARMACEUTICALS INC | 462222100 | $875K | 1.48 | 11,708 | EC | US |
| CRISPR THERAPEUTICS AG | — | $874K | 1.47 | 16,695 | EC | CH |
| THERAVANCE BIOPHARMA INC | — | $872K | 1.47 | 52,082 | EC | KY |
| MADRIGAL PHARMACEUTICALS INC | 558868105 | $856K | 1.44 | 1,655 | EC | US |
| KURA ONCOLOGY INC | 50127T109 | $818K | 1.38 | 92,599 | EC | US |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | $815K | 1.38 | 6,192 | EC | US |
| PTC THERAPEUTICS INC | 69366J200 | $814K | 1.37 | 12,510 | EC | US |
| ACADIA PHARMACEUTICALS INC | 004225108 | $782K | 1.32 | 34,855 | EC | US |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | $757K | 1.28 | 32,610 | EC | US |
| TARSUS PHARMACEUTICALS INC | 87650L103 | $740K | 1.25 | 11,632 | EC | US |
| ALNYLAM PHARMACEUTICALS INC | 02043Q107 | $736K | 1.24 | 2,379 | EC | US |
Page 1
of 2
← Previous
Next →
Sector breakdown
Healthcare
90.0%
Other/Unmapped
10.0%
Institutional owners (13F) 27 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $10,464,537 | 29.65% | 104,374 | Shares | June 30, 2026 |
| ROYAL BANK OF CANADA | $8,916,000 | 25.26% | 92,620 | Shares | June 30, 2026 |
| CWA Asset Management Group, LLC | $1,791,174 | 5.07% | 18,606 | Shares | June 30, 2026 |
| ENVESTNET ASSET MANAGEMENT INC | $1,755,458 | 4.97% | 18,235 | Shares | June 30, 2026 |
| Cetera Investment Advisers | $1,702,510 | 4.82% | 17,685 | Shares | June 30, 2026 |
| TWO SIGMA INVESTMENTS, LP | $1,636,566 | 4.64% | 17,000 | Shares | June 30, 2026 |
| WBI INVESTMENTS, LLC | $1,613,080 | 4.57% | 16,756 | Shares | June 30, 2026 |
| LPL Financial LLC | $1,243,501 | 3.52% | 12,917 | Shares | June 30, 2026 |
| Prime Capital Investment Advisors, LLC | $1,146,945 | 3.25% | 11,914 | Shares | June 30, 2026 |
| MORGAN STANLEY | $1,094,574 | 3.10% | 11,370 | Shares | June 30, 2026 |
| Advisor Resource Council | $1,068,550 | 3.03% | 10,761 | Shares | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,037,487 | 2.94% | 10,777 | Shares | June 30, 2026 |
| INDEPENDENT FINANCIAL GROUP, LLC | $719,704 | 2.04% | 7,476 | Shares | June 30, 2026 |
| Kestra Advisory Services, LLC | $400,472 | 1.13% | 4,160 | Shares | June 30, 2026 |
| RAYMOND JAMES FINANCIAL INC | $290,827 | 0.82% | 3,021 | Shares | June 30, 2026 |
| FOUNDERS FINANCIAL SECURITIES LLC | $216,316 | 0.61% | 2,247 | Shares | June 30, 2026 |
| CWM, LLC | $59,556 | 0.17% | 717 | Shares | March 31, 2026 |
| Institute for Wealth Management, LLC. | $34,272 | 0.10% | 356 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $30,124 | 0.09% | 313 | Shares | June 30, 2026 |
| COMERICA BANK | $17,342 | 0.05% | 217 | Shares | Dec. 31, 2025 |
| FIFTH THIRD BANCORP | $14,537 | 0.04% | 151 | Shares | June 30, 2026 |
| Byrne Asset Management LLC | $13,670 | 0.04% | 142 | Shares | June 30, 2026 |
| Steward Partners Investment Advisory, LLC | $11,071 | 0.03% | 115 | Shares | June 30, 2026 |
| Allworth Financial LP | $6,836 | 0.02% | 71 | Shares | June 30, 2026 |
| Glen Eagle Advisors, LLC | $4,813 | 0.01% | 50 | Shares | June 30, 2026 |
| Thrivent Financial for Lutherans | $4,322 | 0.01% | 44,897 | Shares | June 30, 2026 |
| Farther Finance Advisors, LLC | $2,214 | 0.01% | 23 | Shares | June 30, 2026 |
Peer funds
Similar by size
| Fund | AUM |
|---|---|
| FGSM Advisors' Inner Circle Fund II | $59.3M |
| QVOY Ultimus Managers Trust | $59.5M |
| EURL Direxion Shares ETF Trust | $59.6M |
| THLV THOR Financial Technologies Tru… | $59.7M |
| NDIA Global X Funds | $59.8M |
| TMFS RBB Fund, Inc. | $59.2M |
| WBIY Absolute Shares Trust | $59.0M |
| OCTT AIM ETF Products Trust | $58.9M |
| BRKU Direxion Shares ETF Trust | $58.5M |
| JANB ETF Series Solutions | $58.5M |